Additional specificity analysis was conducted to compare the outcomes of GLP-1 RA users with those of patients receiving other second-line antihyperglycemic treatments, including thiazolidinediones (TZDs), DPP-4is, or sulfonylureas (SUs)
[DOI] [PubMed] [Google Scholar] 128.Mayendraraj, A., Rosenkilde, M
The Journey to your Ideal Weight The path to achieving your desired weight is often winding, filled with highs, lows, and plateaus
Learn management strategies and track symptoms with Dose AI for personalized support
If the medication feels warm, do not buy it
The potential for gastrointestinal adverse effects, particularly nausea and vomiting, may lead to dehydration and worsening of renal function in vulnerable patients